Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

416 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups.
Macchia G, Pezzulla D, Russo D, Campitelli M, Lucci S, Fanelli M, Deodato F, Fagotti A, Gambacorta MA, Savarese A, Pignata S, Aristei C, Ferrandina G. Macchia G, et al. Anticancer Drugs. 2025 Jan 8. doi: 10.1097/CAD.0000000000001684. Online ahead of print. Anticancer Drugs. 2025. PMID: 39784120
Stereotactic Body Radiation Therapy for Oligoprogressive Ovarian Cancer Patients Treated During Poly(ADP-Ribose)-Polymerase Inhibitor Maintenance: Efficacy and Adverse Events From the Epimetheo Retrospective Study.
Macchia G, Pezzulla D, Campitelli M, Russo D, Ronzino G, Lucci S, Salutari V, Di Stefano A, Balcet V, Epifani V, Perrucci E, Marchetti C, Distefano MG, Palluzzi E, Autorino R, De Luca V, Giannini R, Rinaldi R, Russo SA, Cilla S, Fagotti A, Gambacorta MA, Scambia G, Deodato F, Ferrandina G. Macchia G, et al. Int J Radiat Oncol Biol Phys. 2025 Feb 1;121(2):465-474. doi: 10.1016/j.ijrobp.2024.09.010. Epub 2024 Sep 8. Int J Radiat Oncol Biol Phys. 2025. PMID: 39255875
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.
Macchia G, Lazzari R, Colombo N, Laliscia C, Capelli G, D'Agostino GR, Deodato F, Maranzano E, Ippolito E, Ronchi S, Paiar F, Scorsetti M, Cilla S, Ingargiola R, Huscher A, Cerrotta AM, Fodor A, Vicenzi L, Russo D, Borghesi S, Perrucci E, Pignata S, Aristei C, Morganti AG, Scambia G, Valentini V, Jereczek-Fossa BA, Ferrandina G. Macchia G, et al. Oncologist. 2020 Feb;25(2):e311-e320. doi: 10.1634/theoncologist.2019-0309. Epub 2019 Oct 10. Oncologist. 2020. PMID: 32043791 Free PMC article.
Systematic review of stereotactic body radiotherapy for nodal metastases.
Deodato F, Macchia G, Buwenge M, Bonetti M, Cilla S, Zamagni A, Re A, Pezzulla D, Cellini F, Strigari L, Valentini V, Morganti AG. Deodato F, et al. Among authors: macchia g. Clin Exp Metastasis. 2021 Feb;38(1):11-29. doi: 10.1007/s10585-020-10071-x. Epub 2021 Jan 16. Clin Exp Metastasis. 2021. PMID: 33452954
Brachytherapy or external beam radiotherapy as a boost in locally advanced cervical cancer: a Gynaecology Study Group in the Italian Association of Radiation and Clinical Oncology (AIRO) review.
Campitelli M, Lazzari R, Piccolo F, Ferrazza P, Marsella AR, Macchia G, Fodor A, Santoni R, Tagliaferri L, Cerrotta A, Aristei C. Campitelli M, et al. Among authors: macchia g. Int J Gynecol Cancer. 2021 Sep;31(9):1278-1286. doi: 10.1136/ijgc-2020-002310. Epub 2021 Feb 25. Int J Gynecol Cancer. 2021. PMID: 33632703 Review.
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD).
Macchia G, Jereczek-Fossa BA, Lazzari R, Cerrotta A, Deodato F, Ippolito E, Aristei C, Gambacorta MA, Scambia G, Valentini V, Ferrandina G. Macchia G, et al. Int J Gynecol Cancer. 2022 Jul 4;32(7):939-943. doi: 10.1136/ijgc-2021-002709. Int J Gynecol Cancer. 2022. PMID: 34155084 Clinical Trial.
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups.
Macchia G, Nardangeli A, Laliscia C, Fodor A, Draghini L, Gentile PC, D'Agostino GR, Balcet V, Bonome P, Ferioli M, Autorino R, Vicenzi L, Raguso A, Borghesi S, Ippolito E, Di Cataldo V, Cilla S, Perrucci E, Campitelli M, Gambacorta MA, Deodato F, Scambia G, Ferrandina G. Macchia G, et al. Int J Gynecol Cancer. 2022 Jun 6;32(6):732-739. doi: 10.1136/ijgc-2021-003237. Int J Gynecol Cancer. 2022. PMID: 35193941
Postoperative treatment of intermediate-risk early stage cervical cancer: results of a survey from the Gynecology Study Group in the AIRO Gyn and MITO Groups.
Perrucci E, Cerrotta A, Macchia G, Augurio A, Campitelli M, De Sanctis V, Lazzari R, Magri E, Marsella AR, Meregalli S, Tamburo M, Ferrandina G, Aristei C. Perrucci E, et al. Among authors: macchia g. Crit Rev Oncol Hematol. 2022 Jun;174:103704. doi: 10.1016/j.critrevonc.2022.103704. Epub 2022 May 6. Crit Rev Oncol Hematol. 2022. PMID: 35533816 Review.
416 results